Ignite Creation Date:
2025-12-25 @ 1:27 AM
Ignite Modification Date:
2025-12-27 @ 11:55 PM
Study NCT ID:
NCT00393094
Status:
TERMINATED
Last Update Posted:
2012-07-13
First Post:
2006-10-25
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Bevacizumab and Irinotecan to Treat Brain Tumors
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-09
Start Date Type:
None
Primary Completion Date:
2010-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-03
Completion Date Type:
ACTUAL
First Submit Date:
2006-10-25
First Submit QC Date:
None
Study First Post Date:
2006-10-26
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2012-03-27
Results First Submit QC Date:
None
Results First Post Date:
2012-07-06
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2012-07-06
Last Update Post Date:
2012-07-13
Last Update Post Date Type:
ESTIMATED